Showing 1 - 11 results of 11 for search 'Nicholas A Gherardin', query time: 0.06s
Refine Results
-
1
-
2
-
3
Atypical natural killer T-cell receptor recognition of CD1d–lipid antigens by Jérôme Le Nours, T. Praveena, Daniel G. Pellicci, Nicholas A. Gherardin, Fiona J. Ross, Ricky T. Lim, Gurdyal S. Besra, Santosh Keshipeddy, Stewart K. Richardson, Amy R. Howell, Stephanie Gras, Dale I. Godfrey, Jamie Rossjohn, Adam P. Uldrich
Published 2016-02-01
Article -
4
Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma by Samantha K Davis, Kevin John Selva, Ester Lopez, Ebene R Haycroft, Wen Shi Lee, Adam K Wheatley, Jennifer A Juno, Amy Adair, Phillip Pymm, Samuel J Redmond, Nicholas A Gherardin, Dale I Godfrey, Wai‐Hong Tham, Stephen J Kent, Amy W Chung
Published 2022-01-01
Article -
5
Direct recognition of an intact foreign protein by an αβ T cell receptor by Catarina F. Almeida, Benjamin S. Gully, Claerwen M. Jones, Lukasz Kedzierski, Sachith D. Gunasinghe, Michael T. Rice, Richard Berry, Nicholas A. Gherardin, Trang T. Nguyen, Yee-Foong Mok, Josephine F. Reijneveld, D. Branch Moody, Ildiko Van Rhijn, Nicole L. La Gruta, Adam P. Uldrich, Jamie Rossjohn, Dale I. Godfrey
Published 2024-10-01
Article -
6
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay by Ester Lopez, Ebene R. Haycroft, Amy Adair, Francesca L. Mordant, Matthew T. O’Neill, Phillip Pymm, Samuel J. Redmond, Wen Shi Lee, Nicholas A. Gherardin, Adam K. Wheatley, Jennifer A. Juno, Kevin J. Selva, Samantha K. Davis, Samantha L. Grimley, Leigh Harty, Damian F.J. Purcell, Kanta Subbarao, Dale I. Godfrey, Stephen J. Kent, Wai-Hong Tham, Amy W. Chung
Published 2021-08-01
Article -
7
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2 by Phillip Pymm, Samuel J. Redmond, Olan Dolezal, Francesca Mordant, Ester Lopez, James P. Cooney, Kathryn C. Davidson, Ebene R. Haycroft, Chee Wah Tan, Rebecca Seneviratna, Samantha L. Grimley, Damian F.J. Purcell, Stephen J. Kent, Adam K. Wheatley, Lin-Fa Wang, Andrew Leis, Alisa Glukhova, Marc Pellegrini, Amy W. Chung, Kanta Subbarao, Adam P. Uldrich, Wai-Hong Tham, Dale I. Godfrey, Nicholas A. Gherardin
Published 2022-11-01
Article -
8
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineResearch in context by Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, Samantha L. Grimley, James P. Cooney, Samuel J. Redmond, Paula Ellenberg, Kathryn C. Davidson, Francesca L. Mordant, Tim Smith, Marianne Gillard, Ester Lopez, Julie McAuley, Chee Wah Tan, Jing J. Wang, Weiguang Zeng, Mason Littlejohn, Runhong Zhou, Jasper Fuk-Woo Chan, Zhi-wei Chen, Airn E. Hartwig, Richard Bowen, Jason M. Mackenzie, Elizabeth Vincan, Joseph Torresi, Katherine Kedzierska, Colin W. Pouton, Tom P. Gordon, Lin-fa Wang, Stephen J. Kent, Adam K. Wheatley, Sharon R. Lewin, Kanta Subbarao, Amy W. Chung, Marc Pellegrini, Trent Munro, Terry Nolan, Steven Rockman, David C. Jackson, Damian F.J. Purcell, Dale I. Godfrey
Published 2023-06-01
Article -
9
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 by Bruce D. Wines, Bruce D. Wines, Bruce D. Wines, Bruce D. Wines, Liriye Kurtovic, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, Li-Jin Chan, Li-Jin Chan, Francesca L. Mordant, Wen Shi Lee, Nicholas A. Gherardin, Sheila K. Patel, Gemma E. Hartley, Phillip Pymm, Phillip Pymm, James P. Cooney, James P. Cooney, James G. Beeson, James G. Beeson, James G. Beeson, James G. Beeson, Dale I. Godfrey, Louise M. Burrell, Menno C. van Zelm, Menno C. van Zelm, Adam K. Wheatley, Adam K. Wheatley, Amy W. Chung, Wai-Hong Tham, Wai-Hong Tham, Kanta Subbarao, Kanta Subbarao, Stephen J. Kent, Stephen J. Kent, Stephen J. Kent, P. Mark Hogarth, P. Mark Hogarth, P. Mark Hogarth
Published 2023-01-01
Article -
10
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 by Bruce D. Wines, Bruce D. Wines, Bruce D. Wines, Bruce D. Wines, Liriye Kurtovic, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, Li-Jin Chan, Li-Jin Chan, Francesca L. Mordant, Wen Shi Lee, Nicholas A. Gherardin, Sheila K. Patel, Gemma E. Hartley, Phillip Pymm, Phillip Pymm, James P. Cooney, James P. Cooney, James G. Beeson, James G. Beeson, James G. Beeson, James G. Beeson, Dale I. Godfrey, Louise M. Burrell, Menno C. van Zelm, Menno C. van Zelm, Adam K. Wheatley, Adam K. Wheatley, Amy W. Chung, Wai-Hong Tham, Wai-Hong Tham, Kanta Subbarao, Kanta Subbarao, Stephen J. Kent, Stephen J. Kent, Stephen J. Kent, P. Mark Hogarth, P. Mark Hogarth, P. Mark Hogarth
Published 2022-07-01
Article -
11
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boo... by Terry M. Nolan, Georgia Deliyannis, Maryanne Griffith, Sabine Braat, Lilith F. Allen, Jennifer Audsley, Amy W. Chung, Marcin Ciula, Nicholas A. Gherardin, Michelle L. Giles, Tom P. Gordon, Samantha L. Grimley, Lana Horng, David C. Jackson, Jennifer A. Juno, Katherine Kedzierska, Stephen J. Kent, Sharon R. Lewin, Mason Littlejohn, Hayley A. McQuilten, Francesca L. Mordant, Thi H.O. Nguyen, Vanessa Pac Soo, Briony Price, Damian F.J. Purcell, Pradhipa Ramanathan, Samuel J. Redmond, Steven Rockman, Zheng Ruan, Joseph Sasadeusz, Julie A. Simpson, Kanta Subbarao, Stewart A. Fabb, Thomas J. Payne, Asuka Takanashi, Chee Wah Tan, Joseph Torresi, Jing Jing Wang, Lin-Fa Wang, Hareth Al-Wassiti, Chinn Yi Wong, Sophie Zaloumis, Colin W. Pouton, Dale I. Godfrey
Published 2023-12-01
Article